Life Sciences Week

Presented by UPMC Enterprises:

From incubators, to accelerators, to strategic and corporate VCs – investors are committing heavily to improving health. In 2018 alone, corporate VC funding in health care grew to $10.9 billion from $2.3 billion in 2013. Fortunately, there are several Pittsburgh-based and nearby organizations that are refusing to be left behind. Pittsburgh, already known as a health care leader, is doubling down by continuing to invest in cutting-edge science and technologies like immunotherapy. Just last year, a $200 million commitment was made to create a center that focuses on advancing the science of cancer care, transplantation, and aging-related diseases. Several other local and national organizations are investing more time and money to create innovative health care applications, software, and products that will ultimately impact not just patients, but investment analysts, principals, and partners. This discussion will address and analyze changes in the role of the strategic investor within the larger VC landscape, and what the future holds for companies seeking strategic and corporate investment.

No Ticket Purchase is required for this event. Please click the bubble to the left of the event title to register. This event will also be added to your "Day at a Glance." You will receive a confirmation email that you have registered for this event and a reminder the day before it occurs.